G Ronco

Summary

Affiliation: CPO Piemonte
Country: Italy

Publications

  1. ncbi request reprint Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 33:41-56. 2009
  2. doi request reprint Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
    Guglielmo Ronco
    Center for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy Electronic address
    Lancet 383:524-32. 2014
  3. pmc A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years
    Cristina Giambi
    Communicable Disease Epidemiology Unit, National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
    BMC Infect Dis 13:74. 2013
  4. ncbi request reprint [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 36:39-54. 2012
  5. ncbi request reprint [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity]
    Renzo Volante
    CPO Piemonte, Torino
    Epidemiol Prev 36:78-86. 2012
  6. ncbi request reprint Effect of circulation and discussion of cervical smears on agreement between laboratories
    G Ronco
    Centre for Cancer Epidemiology and Prevention in Piedmont CPO, Torino, Italy
    Cytopathology 14:115-20. 2003
  7. doi request reprint Process performance of cervical screening programmes in Europe
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centre for Cancer Prevention, via San Francesco da Paola 31, 1023 Torino, Italy
    Eur J Cancer 45:2659-70. 2009
  8. ncbi request reprint [Epidemiology of HPV genital infection and of its complications and use of HPV testing for cervical cancer screening]
    Guglielmo Ronco
    Unità di epidemiologia dei tumori, CPO Piemonte
    Epidemiol Prev 31:86-91. 2007
  9. ncbi request reprint The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment
    Guglielmo Ronco
    Centro per la Prevenzione Oncologica CPO, Torino, Italy
    Gynecol Oncol 107:S230-2. 2007
  10. doi request reprint Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica, Turin, Italy
    J Natl Cancer Inst 100:492-501. 2008

Collaborators

Detail Information

Publications44

  1. ncbi request reprint Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 33:41-56. 2009
    ..0%. The unadjusted detection rate of CIN2 or more severe histology was 2.9 per 1,000 screened women (3.1 standardised on the Italian population, truncated 25-64)...
  2. doi request reprint Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
    Guglielmo Ronco
    Center for Cancer Epidemiology and Prevention, AO City of Health and Science, Turin, Italy Electronic address
    Lancet 383:524-32. 2014
    ..We did a follow-up study of the four randomised trials to investigate these outcomes...
  3. pmc A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years
    Cristina Giambi
    Communicable Disease Epidemiology Unit, National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
    BMC Infect Dis 13:74. 2013
    ..The present study enrolled Italian women aged 18-26 years in order to assess the prevalence and distribution of high-risk (HR) HPV types. Risk-factors correlated with HR-HPV positivity were also described...
  4. ncbi request reprint [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 36:39-54. 2012
    ..0%. The unadjusted detection rate of CIN2 or more severe histology was 3.2 per 1,000 screened women (3.5 standardised on the Italian population, truncated 25-64)...
  5. ncbi request reprint [Cervical cancer screening in Italy: quality of colposcopy and treatment. 2010 activity]
    Renzo Volante
    CPO Piemonte, Torino
    Epidemiol Prev 36:78-86. 2012
    ..1% of those with known treatment). However, 0.7% of all CIN2 and 1.7% of all CIN3 had hysterectomy. Among the 151 women with invasive carcinoma, 10.6% plausibly with microinvasive disease, only one treatment LLETZ is reported...
  6. ncbi request reprint Effect of circulation and discussion of cervical smears on agreement between laboratories
    G Ronco
    Centre for Cancer Epidemiology and Prevention in Piedmont CPO, Torino, Italy
    Cytopathology 14:115-20. 2003
    ..Overall, the intervention increased diagnostic agreement, but its effect varied with laboratory and by diagnostic class and could be transient. Continued programmes of smear exchange and discussion appear to be advisable...
  7. doi request reprint Process performance of cervical screening programmes in Europe
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centre for Cancer Prevention, via San Francesco da Paola 31, 1023 Torino, Italy
    Eur J Cancer 45:2659-70. 2009
    ..Nevertheless, there is a clear need to standardise the cytological and histological classifications used in screening, as well as data registration systems across Europe...
  8. ncbi request reprint [Epidemiology of HPV genital infection and of its complications and use of HPV testing for cervical cancer screening]
    Guglielmo Ronco
    Unità di epidemiologia dei tumori, CPO Piemonte
    Epidemiol Prev 31:86-91. 2007
  9. ncbi request reprint The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment
    Guglielmo Ronco
    Centro per la Prevenzione Oncologica CPO, Torino, Italy
    Gynecol Oncol 107:S230-2. 2007
    ..To study the impact of different cervical cancer screening strategies including HPV testing...
  10. doi request reprint Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica, Turin, Italy
    J Natl Cancer Inst 100:492-501. 2008
    ..HPV-positive women were directly referred to colposcopy if aged 35 or older; if younger, they were retested after 1 year...
  11. ncbi request reprint HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica CPO, Via S Francesco da Paola 31, 10123 Turin, Italy
    Eur J Cancer 43:476-80. 2007
    ..5% (95%CI 58.3-70.3) at age 35-60. In conclusion, triaging by HPV testing performed better in women aged over 35 years than those younger. For older women, HPV triaging should also be considered for managing those with LSIL cytology...
  12. pmc Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centre for Cancer Prevention, Via S Francesco da Paola 31 10123 Turin, Italy
    BMJ 335:28. 2007
    ..To compare the accuracy of conventional cytology with liquid based cytology for primary screening of cervical cancer...
  13. ncbi request reprint HPV testing for primary cervical cancer screening
    Guglielmo Ronco
    Unit of Cancer Epidemiology, CPO Piemonte, Torino 10123, Italy
    Lancet 370:1740-2. 2007
  14. doi request reprint Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
    Guglielmo Ronco
    Centre for Cancer Prevention, Turin, Italy
    Lancet Oncol 11:249-57. 2010
    ..We assessed the efficacy of cervical-cancer screening policies that are based on HPV testing...
  15. ncbi request reprint Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
    Guglielmo Ronco
    Centre for Cancer Prevention CPO, Turin, Italy
    Lancet Oncol 7:547-55. 2006
    ..We aimed to compare conventional screening with an experimental strategy in women aged 25-34 years, and investigate the effect of different criteria of referral to define the best methods of HPV screening...
  16. pmc New paradigms in cervical cancer prevention: opportunities and risks
    Guglielmo Ronco
    Unità di epidemiologia dei tumori, CPO Piemonte, Torino, Italy
    BMC Womens Health 8:23. 2008
    ..Research on how to best screen vaccinated women is a priority. This paper proposes an overview of the plausible impact of new technologies in cervical cancer screening in the near future and in the vaccinated cohorts...
  17. ncbi request reprint Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis
    Guglielmo Ronco
    Centro per la Prevenzione Oncologica del Piemonte CPO, Turin, Italy
    Cancer 99:83-8. 2003
    ..For smears indicated to require further review, the system provides maps (PapMaps) to identify the most abnormal areas of the smear...
  18. ncbi request reprint Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 35:39-54. 2011
    ..2%. The unadjusted detection rate of CIN2 or more severe histology was 3.2 per 1,000 screened women (3.2 standardised on the Italian population, truncated 25-64)...
  19. ncbi request reprint Prevalence of human papillomavirus infection in women in Turin, Italy
    Guglielmo Ronco
    Unit of Cancer Epidemiology, CPO Piemonte, ASO S Giovanni Battista, via San Francesco da Paola 31, 10123 Turin, Italy
    Eur J Cancer 41:297-305. 2005
    ..In conclusion, overall, the female population of Turin showed an HPV prevalence that is intermediate compared with worldwide levels...
  20. pmc Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98
    G Ronco
    Unit of Cancer Epidemiology, Centre for cancer Epidemiology and Prevention CPO Piemonte, via San Francesco da Paola 31, 10123 Torino, Italy
    Br J Cancer 93:376-8. 2005
    ..25 (95% CI 0.13-0.50) for attenders vs non attenders. An organised screening programme can further reduce cervical cancer incidence in an area where substantial spontaneous activity was previously present...
  21. ncbi request reprint Cervical cancer screening in Italy: quality of colposcopy and treatment. 2009 activity
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 35:78-86. 2011
    ..6% of those with known treatment). However 0.4% of all CIN2 and 3.6% of all CIN3 had hysterectomy. Among the 199 women with invasive carcinoma, 12% plausibly with microinvasive disease had only excisional treatment reported...
  22. ncbi request reprint Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial
    Guglielmo Ronco
    Unit of Cancer Epidemiology, Centro per la Prevenzione Oncologica Piemonte, 10123 Turin, Italy
    J Natl Cancer Inst 98:765-74. 2006
    ....
  23. ncbi request reprint A first survey of organized cervical cancer screening programs in Italy. GISCi working group on organization and evaluation. Gruppo Italiano Screening Citologico
    G Ronco
    Department of Oncology, ASL TOI, Center for Cancer Epidemiology and Prevention (CPO, Regione Piemonte, Torino, Italy
    Tumori 84:624-30. 1998
    ..01%. A need for improvement in the process of evaluation and for homogenization of criteria of cytology interpretation was identified: work in this regard is on-going...
  24. ncbi request reprint Extension of organised cervical cancer screening programmes in Italy and their process indicators
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 31:33-47. 2007
    ..The unadjusted detection rate ofhistologically confirmed CIN2 or more severe was 2.7 per 1000 screened women (3.0 per 1000, standardised on the Italian population, truncated 25-64)...
  25. ncbi request reprint Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies
    N Segnan
    C.P.O. Piemonte, Dipartimento di Oncologia, Ospedale S. Giovanni AS, Azienda USLI, Torino, Italy
    Tumori 84:348-53. 1998
    ..Efficiency can be ensured through the adoption of overbooking, provided that attendance levels are regularly monitored...
  26. pmc Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?
    P Armaroli
    SCDO Epidemiologia dei Tumori, Centro Prevenzione Oncologica Regione Piemonte and Azienda Ospedaliero Universitaria S Giovanni Battista di Torino, V San Francesco da Paola 31, Torino 10123, Italy
    Br J Cancer 99:239-44. 2008
    ..23, 95% CI: 0.00-0.46). Over 50 years of age, after four tests at least three false-positive cases are diagnosed for every true positive. Benefits arising from cytological screening is uncertain in well-screened older women...
  27. ncbi request reprint Quality of colposcopy and treatment--data from the national survey of Italian organised cervical screening programmes: 2006 activity
    Renza Volante
    OIRM S Anna, Torino, Italy
    Epidemiol Prev 33:75-82. 2009
    ..9% of those with known treatment). However 0.7% of all CIN2 and 3.4% of all CIN3 had hysterectomy. Among the 100 women with invasive carcinoma, 17% (plausibly with microinvasive disease) had only excisional treatment reported...
  28. ncbi request reprint Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing
    Laura De Marco
    Unit of Cancer Epidemiology, C E R M S, University of Turin, Via Santena 7, 10126 Turin, Italy
    J Clin Virol 38:7-13. 2007
    ..HPV16 is the prevalent HR-type worldwide associated to cervical cancer. Integration of viral DNA promotes a selective cell growth advantage, resulting a risk factor for cancer development...
  29. ncbi request reprint Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients
    M Preti
    Department of Gynecology and Obstetrics, University of Turin, Turin, Italy
    Cancer 88:1869-76. 2000
    ..The identification of prognostic factors in the recurrence of vulvar squamous cell carcinoma is crucial for less invasive treatments...
  30. ncbi request reprint Assessment of specimen adequacy reproducibility: an Italian experience
    Gioia Montanari
    Prevenzione Serena, CPO Piemonte, Torino, Italy
    Diagn Cytopathol 28:224-6. 2003
    ..New Italian guidelines on adequacy proposed the GISCi are presented and the recommendation is made to eliminate the SBLB category...
  31. ncbi request reprint Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits
    Anna Gillio-Tos
    Unit of Cancer Epidemiology, C E R M S, University of Turin, Via Santena 7, 10126 Turin, Italy
    J Clin Virol 36:126-32. 2006
    ..Infection with human papillomavirus (HPV) is a necessary step in the progression to cervical cancer. Many methods for HPV testing are currently available, most developed to detect pools of HPV types...
  32. ncbi request reprint Extension of organised cervical cancer screening programmes in Italy and their process indicators
    Guglielmo Ronco
    CPO Piemonte, Torino
    Epidemiol Prev 32:37-54. 2008
    ..The unadjusted detection rate of histologically confirmed CIN2 or more severe was 2.7 per 1,000 screened women (2.6 standardised on the Italian population, truncated 25-64)...
  33. ncbi request reprint Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys
    Salvatore Vaccarella
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    Cancer Epidemiol Biomarkers Prev 15:2148-53. 2006
    ....
  34. ncbi request reprint Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting
    Francesca Maria Carozzi
    Center for Study and Prevention of Cancer CSPO, Florence, Italy
    Am J Clin Pathol 124:716-21. 2005
    ..91, 0.60, and 0.69 with PreservCyt and 0.93, 0.87, and 0.90 with STM. Our data showed high reliability and reproducibility with HC2, with values higher for STM than ThinPrep (Cytyc) samples...
  35. ncbi request reprint A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
    Philip Davies
    European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France
    Int J Cancer 118:791-6. 2006
    ..Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test...
  36. ncbi request reprint Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes
    Renza Volante
    Azienda Sanitaria Ospedaliera OIRM Sant Anna, Torino
    Epidemiol Prev 31:61-8. 2007
    ..However, 0.8% of women with CIN2 and 4.2% of women with CIN3 had hysterectomy. Of the 76 women with invasive carcinoma, 19.8%, plausibly with microinvasive disease, had excisional treatment only reported...
  37. ncbi request reprint Activity level and process indicators of organised programmes for cervical cancer screening in Italy
    Guglielmo Ronco
    Centro Prevenzione Oncologica, Torino
    Epidemiol Prev 30:27-40. 2006
    ..Despite this rise, quality indicators were stable. However, in a few programmes, the use of excessively broad criteria in the interpretation of cytology decides an excessively high rate of referrals to colposcopy...
  38. ncbi request reprint The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective
    Paolo Giorgi-Rossi
    Agency for Public Health, Lazio Region, Rome, Italy
    Int J Cancer 121:2729-34. 2007
    ..If HPV testing is applied with cytology-triage, a single HPV test may cost 20-30% more than a conventional Pap to result in the same overall cost per CIN2+ detected...
  39. pmc Cervical intraepithelial neoplasia and higher long term risk of cancer
    Guglielmo Ronco
    BMJ 335:1053-4. 2007
  40. ncbi request reprint National survey of the quality of 2nd level in screening for cervical cancer
    Renza Volante
    Azienda Ospedaliera O I R M Sant Anna, Torino
    Epidemiol Prev 30:51-7. 2006
    ..Some 0.7% of all CIN2 and 5.1% of all CIN3 had hysterectomy. Some 12% of the 111 invasive carcinoma, plausibly microinvasive, had excisional treatment only...
  41. ncbi request reprint The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trial
    Paolo Dalla Palma
    Pathology Unit, S Chiara Hospital of Trento, Trento, Italy
    Am J Clin Pathol 129:75-80. 2008
    ..015). In screening, a low positive predictive value of the colposcopy-referring test may result in unnecessary treatments...
  42. ncbi request reprint Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes
    Renza Volante
    OIRM S Anna, Torino
    Epidemiol Prev 32:69-76. 2008
    ..6% of those with known treatment). However, 1.5 % of all CIN2 and 5.5 % of all CIN3 had hysterectomy. Among the 140 women with invasive carcinoma 17.8%, plausibly with microinvasive disease, had excisional treatment only reported...
  43. ncbi request reprint Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006
    ..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
  44. ncbi request reprint Chapter 10: New dimensions in cervical cancer screening
    Jack Cuzick
    Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London, United Kingdom
    Vaccine 24:S3/90-7. 2006
    ..The fact that HPV is a sexually transmitted infection may lead to anxiety and concerns about sexual relationships and these issues are also discussed. Ongoing HPV studies are identified and briefly reviewed...